Health - Google News: Celgene's Abraxane meets main goal in melanoma trial - Reuters

Health - Google News Google News

Celgene's Abraxane meets main goal in melanoma trial - Reuters Oct 2nd 2012, 12:10 Celgene's Abraxane meets main goal in melanoma trial Reuters (Reuters) - Celgene Corp said a late-stage trial of its cancer drug Abraxane met its main goal of improving the patient's time of survival without worsening skin cancer, when compared to standard chemotherapy. Abraxane is already approved to treat ... Celgene's Abraxane meets key endpoint in studyMarketWatch ABRAXANE Meets Primary Endpoint In Phase III CA033 Study - Quick FactsNASDAQ ABRAXANE Meets Primary Endpoint of Progression-Free Survival in Phase III ...National Post all 23 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: